RxNorm Semantic Concepts Index - 228
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "228".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 228014 | Venombin A | Designated preferred name (PT) | NO | |
| RxCUI: 228014 | Venombin A | Full form of descriptor (FN) | NO | |
| RxCUI: 228015 | Cotazym | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2280291 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2280291 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2280291 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2280291 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2280291 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2280291 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2280291 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2280292 | N-acetyl-.alpha.-D-glucosamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2280293 | influenza B virus B/Washington/02/2019 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2280296 | influenza A virus A/South Australia/34/2019 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 228041 | Echinacea extract | Designated preferred name (PT) | YES | |
| RxCUI: 228041 | Echinacea extract | Designated preferred name (PT) | YES | |
| RxCUI: 228041 | Echinacea extract | Full form of descriptor (FN) | YES | |
| RxCUI: 228041 | Echinacea extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 228041 | Echinacea extract | Full form of descriptor (FN) | YES | |
| RxCUI: 228041 | Echinacea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 228041 | Echinacea extract | Designated preferred name (PT) | YES | |
| RxCUI: 228041 | Echinacea extract | Full form of descriptor (FN) | YES | |
| RxCUI: 228054 | Dexmedetomidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 228054 | Dexmedetomidine hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 228054 | Dexmedetomidine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 228054 | Dexmedetomidine hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2280602 | strontium cation Sr-89 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2280603 | aluminum iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2280709 | magnesium hydroxide 1200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2280709 | magnesium hydroxide 1200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2280728 | zinc oxide 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2280729 | zinc oxide 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2280729 | zinc oxide 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2280729 | zinc oxide 1.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2280729 | zinc oxide 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2280730 | trastuzumab-qyyp | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2280731 | trastuzumab-qyyp 21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2280732 | trastuzumab-qyyp 420 MG in 20 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2280732 | trastuzumab-qyyp 420 MG in 20 ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2280732 | trastuzumab-qyyp 420 MG in 20 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2280733 | Trazimera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2280734 | trastuzumab-qyyp 21 MG/ML [Trazimera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2280735 | trastuzumab Injectable Solution [Trazimera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2280736 | Trazimera Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2280737 | Trazimera 420 MG in 20 mL Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2280737 | Trazimera 420 MG in 20 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2280737 | Trazimera 420 MG in 20 mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2280737 | Trazimera 420 MG in 20 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2280739 | influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2280740 | influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2280741 | influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2280742 | influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2280743 | Fluzone Quadrivalent 2020 Southern Hemisphere | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2280744 | influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020 Southern Hemisphere] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2280745 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2280746 | Fluzone Quadrivalent 2020 Southern Hemisphere Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2280747 | influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2280748 | influenza A virus (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2280749 | influenza A virus (H3N2) antigen / influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2280750 | 0.25 ML influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2280751 | influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020 Southern Hemisphere] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2280752 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.25 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2280752 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2280752 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2280753 | influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2280754 | influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2280755 | influenza virus vaccine 2020 (quadrivalent - Brisbane/South Australia/Phuket/Washington) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2280755 | influenza virus vaccine 2020 (quadrivalent - Brisbane/South Australia/Phuket/Washington) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2280756 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2280756 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2280756 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2280761 | Charlotte 24 Fe Chewable 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2280761 | Charlotte 24 Fe Chewable 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2280761 | Charlotte 24 Fe Chewable 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 228080 | pirenoxine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2280908 | Drosera rotundifolia flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2281102 | nonoxynol-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2281104 | meloxicam 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2281105 | meloxicam Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2281106 | meloxicam 30 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2281106 | meloxicam 30 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2281106 | meloxicam 30 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281107 | Anjeso | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2281108 | meloxicam 30 MG/ML [Anjeso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2281109 | meloxicam Injection [Anjeso] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2281110 | Anjeso Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2281111 | Anjeso 30 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281111 | Anjeso 30 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2281111 | Anjeso 30 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2281111 | Anjeso 30 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281112 | meloxicam 30 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281113 | meloxicam 30 MG/ML Injection [Anjeso] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281113 | meloxicam 30 MG/ML Injection [Anjeso] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2281114 | deutetrabenazine starter pack 6 MG (14), 9 MG (14) Oral Tablet 2 Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2281114 | deutetrabenazine starter pack 6 MG (14), 9 MG (14) Oral Tablet 2 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2281114 | deutetrabenazine starter pack 6 MG (14), 9 MG (14) Oral Tablet 2 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281115 | Austedo Tardive Dyskinesia 12 MG Starting Dose Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2281115 | Austedo Tardive Dyskinesia 12 MG Starting Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281115 | Austedo Tardive Dyskinesia 12 MG Starting Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2281116 | deutetrabenazine starter pack 6 MG (21) Oral Tablet 2 Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2281116 | deutetrabenazine starter pack 6 MG (21) Oral Tablet 2 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281116 | deutetrabenazine starter pack 6 MG (21) Oral Tablet 2 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281117 | Austedo (Chorea associated w/Huntington's disease) 6 MG Starting Dose Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 2281117 | Austedo (Chorea associated w/Huntington's disease) 6 MG Starting Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281117 | Austedo (Chorea associated w/Huntington's disease) 6 MG Starting Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281302 | bacitracin 500 UNT / lidocaine HCl 40 MG / neomycin 3.5 MG / polymyxin B 5,000 UNT per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2281302 | bacitracin 500 UNT / lidocaine HCl 40 MG / neomycin 3.5 MG / polymyxin B 5,000 UNT per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2281302 | bacitracin 500 UNT / lidocaine HCl 40 MG / neomycin 3.5 MG / polymyxin B 5,000 UNT per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281303 | olopatadine 1 MG/ML [Pataday] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2281304 | Pataday Twice Daily 0.1 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2281304 | Pataday Twice Daily 0.1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281304 | Pataday Twice Daily 0.1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281304 | Pataday Twice Daily 0.1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2281305 | panthenol 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281306 | panthenol Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2281307 | panthenol 1.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281307 | panthenol 1.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281307 | panthenol 1.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281308 | Maclura cochinchinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2281309 | 2-hexenal, (2e)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2281310 | 2-methylbutanoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281310 | 2-methylbutanoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2281589 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2281668 | influenza virus vaccine 2020 (quadrivalent - Brisbane/South Australia/Phuket/Washington) Injectable Suspension, southern hemisphere | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281668 | influenza virus vaccine 2020 (quadrivalent - Brisbane/South Australia/Phuket/Washington) Injectable Suspension, southern hemisphere | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281668 | influenza virus vaccine 2020 (quadrivalent - Brisbane/South Australia/Phuket/Washington) Injectable Suspension, southern hemisphere | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281669 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281669 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281669 | Fluzone Quadrivalent 2020 Southern Hemisphere vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2281670 | Ruttnera lamellosa oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2281671 | Dicrateria rotunda oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2281672 | citronellene lactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2281673 | zeolite A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2281674 | 1,2-dimercaptopropane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281674 | 1,2-dimercaptopropane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2281728 | moxidectin 0.24 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281729 | pyrantel pamoate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281730 | sarolaner 12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281731 | moxidectin / pyrantel / sarolaner Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2281732 | moxidectin / pyrantel / sarolaner Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2281733 | moxidectin / pyrantel / sarolaner Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2281734 | moxidectin / pyrantel / sarolaner Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2281735 | moxidectin / pyrantel / sarolaner | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2281736 | moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281736 | moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281737 | Simparica TRIO | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2281738 | moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG [Simparica TRIO] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281739 | moxidectin / pyrantel / sarolaner Chewable Tablet [Simparica TRIO] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2281740 | Simparica TRIO Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2281741 | Simparica TRIO Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2281742 | Simparica TRIO Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2281743 | Simparica TRIO 0.24 MG / 50 MG / 12 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2281743 | Simparica TRIO 0.24 MG / 50 MG / 12 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281743 | Simparica TRIO 0.24 MG / 50 MG / 12 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281744 | moxidectin 0.48 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281745 | pyrantel pamoate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281746 | sarolaner 24 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281747 | moxidectin 0.48 MG / pyrantel pamoate 100 MG / sarolaner 24 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281747 | moxidectin 0.48 MG / pyrantel pamoate 100 MG / sarolaner 24 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281748 | moxidectin 0.48 MG / pyrantel pamoate 100 MG / sarolaner 24 MG [Simparica TRIO] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281749 | Simparica TRIO 0.48 MG / 100 MG / 24 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2281749 | Simparica TRIO 0.48 MG / 100 MG / 24 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281749 | Simparica TRIO 0.48 MG / 100 MG / 24 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281750 | moxidectin 0.06 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281751 | pyrantel pamoate 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281752 | sarolaner 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281753 | moxidectin 0.06 MG / pyrantel pamoate 12.5 MG / sarolaner 3 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281753 | moxidectin 0.06 MG / pyrantel pamoate 12.5 MG / sarolaner 3 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281754 | moxidectin 0.06 MG / pyrantel pamoate 12.5 MG / sarolaner 3 MG [Simparica TRIO] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281755 | Simparica TRIO 0.06 MG / 12.5 MG / 3 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2281755 | Simparica TRIO 0.06 MG / 12.5 MG / 3 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281755 | Simparica TRIO 0.06 MG / 12.5 MG / 3 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281756 | moxidectin 0.96 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281757 | pyrantel pamoate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281758 | sarolaner 48 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281759 | moxidectin 0.96 MG / pyrantel pamoate 200 MG / sarolaner 48 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281759 | moxidectin 0.96 MG / pyrantel pamoate 200 MG / sarolaner 48 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281760 | moxidectin 0.96 MG / pyrantel pamoate 200 MG / sarolaner 48 MG [Simparica TRIO] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281761 | Simparica TRIO 0.96 MG / 200 MG / 48 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2281761 | Simparica TRIO 0.96 MG / 200 MG / 48 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281761 | Simparica TRIO 0.96 MG / 200 MG / 48 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281762 | moxidectin 0.12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281763 | pyrantel pamoate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281764 | sarolaner 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281765 | moxidectin 0.12 MG / pyrantel pamoate 25 MG / sarolaner 6 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281765 | moxidectin 0.12 MG / pyrantel pamoate 25 MG / sarolaner 6 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281766 | moxidectin 0.12 MG / pyrantel pamoate 25 MG / sarolaner 6 MG [Simparica TRIO] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281767 | Simparica TRIO 0.12 MG / 25 MG / 6 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2281767 | Simparica TRIO 0.12 MG / 25 MG / 6 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281767 | Simparica TRIO 0.12 MG / 25 MG / 6 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281768 | moxidectin 1.44 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281769 | pyrantel pamoate 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281770 | sarolaner 72 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281771 | moxidectin 1.44 MG / pyrantel pamoate 300 MG / sarolaner 72 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281771 | moxidectin 1.44 MG / pyrantel pamoate 300 MG / sarolaner 72 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281772 | moxidectin 1.44 MG / pyrantel pamoate 300 MG / sarolaner 72 MG [Simparica TRIO] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281773 | Simparica TRIO 1.44 MG / 300 MG / 72 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2281773 | Simparica TRIO 1.44 MG / 300 MG / 72 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2281773 | Simparica TRIO 1.44 MG / 300 MG / 72 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281777 | calcium carbonate 750 MG Chewing Gum | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281777 | calcium carbonate 750 MG Chewing Gum | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281817 | 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281833 | carbetapentane tannate 4.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281834 | phenylephrine tannate 1.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281838 | phenylephrine tannate 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281843 | calcium carbonate 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2281844 | calcium carbonate 1200 MG / magnesium hydroxide 270 MG / simethicone 80 MG per 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2281844 | calcium carbonate 1200 MG / magnesium hydroxide 270 MG / simethicone 80 MG per 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2281844 | calcium carbonate 1200 MG / magnesium hydroxide 270 MG / simethicone 80 MG per 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281845 | phenylephrine hydrochloride 1.5 MG/ML / potassium guaiacolsulfonate 20 MG/ML [Lusonal Reformulated Oct 2008] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281848 | acetaminophen 60 MG/ML / oxycodone hydrochloride 2 MG/ML [Prolate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2281848 | acetaminophen 60 MG/ML / oxycodone hydrochloride 2 MG/ML [Prolate] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2281849 | acetaminophen / oxycodone Oral Solution [Prolate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2281849 | acetaminophen / oxycodone Oral Solution [Prolate] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2281850 | Prolate Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2281851 | Prolate 10 MG / 300 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2281851 | Prolate 10 MG / 300 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2281851 | Prolate 10 MG / 300 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281851 | Prolate 10 MG / 300 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2281851 | Prolate 10 MG / 300 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2281851 | Prolate 10 MG / 300 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2281851 | Prolate 10 MG / 300 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2281855 | pyrilamine tannate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2281857 | carbetapentane tannate 60 MG / phenylephrine tannate 10 MG / pyrilamine tannate 40 MG [Tussi-12D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281864 | empagliflozin / linagliptin / metformin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2281864 | empagliflozin / linagliptin / metformin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2281868 | dexbrompheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML [Cytuss-HC NR] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281868 | dexbrompheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML [Cytuss-HC NR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2281870 | dexbrompheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML [H C Tussive-NR] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281870 | dexbrompheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML [H C Tussive-NR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2281872 | ampicillin 250 MG/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2281872 | ampicillin 250 MG/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2281873 | ampicillin Injectable Suspension [Polyflex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2281876 | cholecalciferol 1.25 MG [Dialyvite Vitamin D3 Max] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2281878 | cholecalciferol 1.25 MG [Decalcitrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2281880 | cholecalciferol 0.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2281883 | cholecalciferol 0.1 MG [Thera-D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2281885 | cholecalciferol 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2281887 | cholecalciferol 0.25 MG [Decara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282002 | Cefenil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2282003 | ceftiofur 50 MG/ML [Cefenil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282004 | ceftiofur Injectable Suspension [Cefenil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2282005 | Cefenil Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2282006 | CEFENIL RTU 50 MG/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282006 | CEFENIL RTU 50 MG/ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282006 | CEFENIL RTU 50 MG/ML Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2282010 | phenylephrine HCl 2.5 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282010 | phenylephrine HCl 2.5 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282010 | phenylephrine HCl 2.5 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2282011 | Mederma for Kids | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2282012 | allantoin 0.01 MG/MG [Mederma for Kids] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2282013 | allantoin Topical Gel [Mederma for Kids] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2282014 | Mederma for Kids Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2282015 | Mederma for Kids 1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2282015 | Mederma for Kids 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282015 | Mederma for Kids 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282015 | Mederma for Kids 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282016 | calcium carbonate 1330 MG / magnesium hydroxide 235 MG / simethicone 40 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282016 | calcium carbonate 1330 MG / magnesium hydroxide 235 MG / simethicone 40 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2282017 | aflatoxin B1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2282018 | isatuximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2282018 | isatuximab | Designated preferred name (PT) | YES | |
| RxCUI: 2282018 | isatuximab | Full form of descriptor (FN) | YES | |
| RxCUI: 2282018 | isatuximab | Designated preferred name (PT) | YES | |
| RxCUI: 2282018 | isatuximab | Full form of descriptor (FN) | YES | |
| RxCUI: 2282019 | isatuximab-irfc | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2282020 | isatuximab-irfc 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2282021 | isatuximab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2282021 | isatuximab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2282021 | isatuximab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2282022 | isatuximab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2282023 | isatuximab-irfc 100 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2282023 | isatuximab-irfc 100 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282023 | isatuximab-irfc 100 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282024 | Sarclisa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2282025 | isatuximab-irfc 20 MG/ML [Sarclisa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2282026 | isatuximab Injection [Sarclisa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2282027 | Sarclisa Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2282028 | Sarclisa 100 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2282028 | Sarclisa 100 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282028 | Sarclisa 100 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282028 | Sarclisa 100 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282029 | isatuximab-irfc 20 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2282030 | isatuximab-irfc 20 MG/ML Injection [Sarclisa] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2282030 | isatuximab-irfc 20 MG/ML Injection [Sarclisa] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282031 | isatuximab-irfc 500 MG in 25 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2282031 | isatuximab-irfc 500 MG in 25 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282031 | isatuximab-irfc 500 MG in 25 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282032 | Sarclisa 500 MG in 25 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2282032 | Sarclisa 500 MG in 25 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282032 | Sarclisa 500 MG in 25 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282032 | Sarclisa 500 MG in 25 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282112 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282112 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2282112 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 22822 | mebhydrolin napadisylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2282202 | phenylephrine HCl 1 MG/mL / pyrilamine maleate 3.2 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282202 | phenylephrine HCl 1 MG/mL / pyrilamine maleate 3.2 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2282203 | phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 3.2 MG/ML [Aldex D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282204 | ALDEX D 5 MG / 16 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282204 | ALDEX D 5 MG / 16 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282204 | ALDEX D 5 MG / 16 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2282205 | phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 3.2 MG/ML [Pyril D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282206 | PYRIL D 5 MG / 16 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2282206 | PYRIL D 5 MG / 16 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282206 | PYRIL D 5 MG / 16 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282207 | phenylephrine HCl 10 MG / pyrilamine maleate 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282207 | phenylephrine HCl 10 MG / pyrilamine maleate 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2282208 | phenylephrine hydrochloride 10 MG / pyrilamine maleate 30 MG [Ru Hist D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282209 | RU-HIST-D 30 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2282209 | RU-HIST-D 30 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282209 | RU-HIST-D 30 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282305 | menthone, (+)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2282306 | menthyl acetate, (+/-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2282307 | Product containing rimegepant (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2282307 | Product containing rimegepant (medicinal product) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2282307 | Product containing rimegepant (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2282307 | Product containing rimegepant (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2282307 | Product containing rimegepant (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2282313 | rimegepant 75 MG Disintegrating Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2282313 | rimegepant 75 MG Disintegrating Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2282313 | rimegepant 75 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282313 | rimegepant 75 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282313 | rimegepant 75 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2282314 | Nurtec | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2282317 | Nurtec Disintegrating Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2282318 | Nurtec Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2282319 | Nurtec Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2282320 | Nurtec ODT 75 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282320 | Nurtec ODT 75 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282320 | Nurtec ODT 75 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282320 | Nurtec ODT 75 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2282322 | rimegepant sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2282322 | rimegepant sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 2282322 | rimegepant sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 2282323 | Isatis tinctoria whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2282403 | bempedoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2282403 | bempedoic acid | Designated preferred name (PT) | YES | |
| RxCUI: 2282403 | bempedoic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 2282403 | bempedoic acid | Designated preferred name (PT) | YES | |
| RxCUI: 2282403 | bempedoic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 2282404 | bempedoic acid 180 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2282405 | bempedoic acid Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2282405 | bempedoic acid Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2282405 | bempedoic acid Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2282406 | bempedoic acid Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2282407 | bempedoic acid Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2282408 | bempedoic acid 180 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282408 | bempedoic acid 180 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2282408 | bempedoic acid 180 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2282408 | bempedoic acid 180 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2282409 | Nexletol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2282410 | bempedoic acid 180 MG [Nexletol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2282411 | bempedoic acid Oral Tablet [Nexletol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2282412 | Nexletol Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2282413 | Nexletol Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2282414 | NEXLETOL 180 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2282414 | NEXLETOL 180 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2282414 | NEXLETOL 180 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2282514 | lymphocyte immune globulin, anti-thymocyte globulin, equine 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2282515 | lymphocyte immune globulin, anti-thymocyte globulin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2282516 | lymphocyte immune globulin, anti-thymocyte globulin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2282518 | lymphocyte immune globulin, anti-thymocyte globulin, equine 50 MG/ML [ATGAM] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2282519 | lymphocyte immune globulin, anti-thymocyte globulin Injection [ATGAM] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2282525 | rabbit anti-human T-lymphocyte globulin 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2282527 | rabbit anti-human T-lymphocyte globulin 25 MG [Thymoglobulin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2282528 | lymphocyte immune globulin, anti-thymocyte globulin Injection [Thymoglobulin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2282658 | camphor 32 MG/ML [Jointflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282659 | Jointflex 3.2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2282659 | Jointflex 3.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282659 | Jointflex 3.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282660 | eptinezumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2282660 | eptinezumab | Designated preferred name (PT) | YES | |
| RxCUI: 2282660 | eptinezumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2282660 | eptinezumab | Designated preferred name (PT) | YES | |
| RxCUI: 2282660 | eptinezumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2282661 | propylene glycol 1-myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 228271 | Rebif | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2282752 | water 700 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2282753 | water 70 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282753 | water 70 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282753 | water 70 % Ophthalmic Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2282756 | poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2282758 | poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Suspension [Ipol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2282766 | pyrilamine tannate 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2282771 | phenylpropanolamine hydrochloride 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2282778 | Human adenovirus 40 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282848 | guaifenesin 24 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.2 MG/ML [Donatussin DC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282848 | guaifenesin 24 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.2 MG/ML [Donatussin DC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282851 | guaifenesin 30 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.2 MG/ML [Tussafed-HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282851 | guaifenesin 30 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.2 MG/ML [Tussafed-HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282853 | guaifenesin 30 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.2 MG/ML [Hydrofed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282853 | guaifenesin 30 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.2 MG/ML [Hydrofed] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282861 | pheniramine maleate 0.66 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2282862 | phenylpropanolamine hydrochloride 0.66 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2282863 | pyrilamine maleate 0.66 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2282877 | hydrocodone bitartrate 0.7 MG/ML / phenylephrine hydrochloride 1.5 MG/ML / pyrilamine maleate 2.5 MG/ML [Poly Hist HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282877 | hydrocodone bitartrate 0.7 MG/ML / phenylephrine hydrochloride 1.5 MG/ML / pyrilamine maleate 2.5 MG/ML [Poly Hist HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282880 | hydrocodone bitartrate 0.75 MG/ML / phenylephrine hydrochloride 1.5 MG/ML [Tusdec HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282880 | hydrocodone bitartrate 0.75 MG/ML / phenylephrine hydrochloride 1.5 MG/ML [Tusdec HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282882 | hydrocodone bitartrate 0.75 MG/ML / phenylephrine hydrochloride 1.5 MG/ML [Lortuss HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282882 | hydrocodone bitartrate 0.75 MG/ML / phenylephrine hydrochloride 1.5 MG/ML [Lortuss HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282884 | pyrilamine maleate 2.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2282886 | hydrocodone bitartrate 1.2 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 2.4 MG/ML [Tussplex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282886 | hydrocodone bitartrate 1.2 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 2.4 MG/ML [Tussplex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282892 | phenylephrine hydrochloride 1.5 MG/ML [Lusonal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282894 | pyrilamine tannate 2.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2282896 | phenylephrine tannate 1.8 MG/ML / pyrilamine tannate 2.4 MG/ML [Pyrlex PD] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282903 | phenylephrine tannate 25 MG / pyrilamine tannate 60 MG [Ryna-12] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282905 | calenduladiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2282906 | phenylephrine tannate 25 MG / pyrilamine tannate 60 MG [K Tan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282909 | carbetapentane citrate 4 MG/ML / phenylephrine hydrochloride 2 MG/ML / potassium guaiacolsulfonate 20 MG/ML [Carbatuss-CL] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282911 | ethanol 71 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2282911 | ethanol 71 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2282911 | ethanol 71 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2282913 | dexbrompheniramine tannate 0.8 MG/ML / pyrilamine maleate 0.7 MG/ML [Poly Tan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282917 | hydrocodone bitartrate 1 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1 MG/ML [Mintuss MR] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282917 | hydrocodone bitartrate 1 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1 MG/ML [Mintuss MR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282920 | hydrocodone bitartrate 1 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1 MG/ML [Atuss MR] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282920 | hydrocodone bitartrate 1 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1 MG/ML [Atuss MR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2282922 | hydrocodone bitartrate 1 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1 MG/ML [De-Chlor MR] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2282922 | hydrocodone bitartrate 1 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1 MG/ML [De-Chlor MR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283 | Cetomacrogol | Designated preferred name (PT) | NO | |
| RxCUI: 2283 | Cetomacrogol | Full form of descriptor (FN) | NO | |
| RxCUI: 2283031 | Gossypium hirsutum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2283032 | salicylic acid 0.02 MG/MG [Stridex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2283033 | salicylic acid Topical Gel [Stridex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2283037 | vitamin E 180 MG [Aquasol E] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2283039 | vitamin E 90 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2283042 | vitamin E 90 MG [Amino-Opti-E] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2283045 | eptinezumab-jjmr | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2283046 | eptinezumab-jjmr 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2283047 | eptinezumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2283047 | eptinezumab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2283047 | eptinezumab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2283048 | eptinezumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2283049 | eptinezumab-jjmr 100 MG in 1 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2283049 | eptinezumab-jjmr 100 MG in 1 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283049 | eptinezumab-jjmr 100 MG in 1 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283050 | Vyepti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2283051 | eptinezumab-jjmr 100 MG/ML [Vyepti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2283052 | eptinezumab Injection [Vyepti] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2283053 | Vyepti Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2283054 | vyepti 100 MG in 1 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2283054 | vyepti 100 MG in 1 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283054 | vyepti 100 MG in 1 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283054 | vyepti 100 MG in 1 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283055 | eptinezumab-jjmr 100 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283056 | eptinezumab-jjmr 100 MG/ML Injection [Vyepti] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2283056 | eptinezumab-jjmr 100 MG/ML Injection [Vyepti] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283060 | scopolamine hydrobromide 0.125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2283064 | codeine polistirex 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2283066 | chlorpheniramine polistirex 0.8 MG/ML / codeine polistirex 4 MG/ML [Codeprex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2283069 | chlorpheniramine tannate 0.8 MG/ML / hydrocodone tannate 1 MG/ML [Novasus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2283069 | chlorpheniramine tannate 0.8 MG/ML / hydrocodone tannate 1 MG/ML [Novasus] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283073 | chlorpheniramine maleate 1 MG/ML / codeine phosphate 2 MG/ML / phenylephrine hydrochloride 4 MG/ML / phenylpropanolamine hydrochloride 4 MG/ML [T Koff] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2283080 | phenindamine tartrate 24 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2283225 | Tanacetum coccineum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2283226 | bempedoic acid / ezetimibe Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2283226 | bempedoic acid / ezetimibe Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2283226 | bempedoic acid / ezetimibe Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2283227 | bempedoic acid / ezetimibe Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2283228 | bempedoic acid / ezetimibe Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2283229 | bempedoic acid / ezetimibe | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2283229 | bempedoic acid / ezetimibe | Designated preferred name (PT) | YES | |
| RxCUI: 2283229 | bempedoic acid / ezetimibe | Full form of descriptor (FN) | YES | |
| RxCUI: 2283230 | bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283230 | bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2283230 | bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2283230 | bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2283231 | Nexlizet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2283232 | bempedoic acid 180 MG / ezetimibe 10 MG [Nexlizet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2283233 | bempedoic acid / ezetimibe Oral Tablet [Nexlizet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2283234 | Nexlizet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2283235 | Nexlizet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2283236 | Nexlizet 180 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2283236 | Nexlizet 180 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283236 | Nexlizet 180 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283237 | chlorpheniramine maleate 650 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2283238 | phenylpropanolamine hydrochloride 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2283239 | APAP 25 MG / Chlorpheniramine Maleate 650 MG / Phenylpropanolamine Hydrochloride 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283239 | APAP 25 MG / Chlorpheniramine Maleate 650 MG / Phenylpropanolamine Hydrochloride 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283239 | APAP 25 MG / Chlorpheniramine Maleate 650 MG / Phenylpropanolamine Hydrochloride 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283240 | APAP 325 MG / Caffeine 32.5 MG / Chlorpheniramine Maleate 2 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283240 | APAP 325 MG / Caffeine 32.5 MG / Chlorpheniramine Maleate 2 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283240 | APAP 325 MG / Caffeine 32.5 MG / Chlorpheniramine Maleate 2 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283241 | APAP 325 MG / Chlorpheniramine Maleate 1 MG / Guaifenesin 25 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283241 | APAP 325 MG / Chlorpheniramine Maleate 1 MG / Guaifenesin 25 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283241 | APAP 325 MG / Chlorpheniramine Maleate 1 MG / Guaifenesin 25 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283241 | APAP 325 MG / Chlorpheniramine Maleate 1 MG / Guaifenesin 25 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283241 | APAP 325 MG / Chlorpheniramine Maleate 1 MG / Guaifenesin 25 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283241 | APAP 325 MG / Chlorpheniramine Maleate 1 MG / Guaifenesin 25 MG / Phenylpropanolamine Hydrochloride 12.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283242 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylpropanolamine HCl 12.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2283242 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylpropanolamine HCl 12.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283242 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylpropanolamine HCl 12.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283242 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylpropanolamine HCl 12.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283243 | chlorpheniramine maleate 0.4 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283246 | chlorpheniramine maleate 4 MG / phenylpropanolamine hydrochloride 25 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283249 | chlorpheniramine maleate 4 MG / phenylpropanolamine hydrochloride 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283254 | chlorpheniramine maleate 4 MG / phenylpropanolamine hydrochloride 37.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283257 | chlorpheniramine maleate 4 MG / phenylpropanolamine hydrochloride 75 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283258 | chlorpheniramine maleate 4 MG / phenylpropanolamine hydrochloride 37.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283402 | butyl cyanoacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2283502 | cenobamate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2283503 | cenobamate 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283503 | cenobamate 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2283504 | cenobamate 100 MG [Xcopri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2283505 | XCOPRI 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2283505 | XCOPRI 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283505 | XCOPRI 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283506 | cenobamate 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2283507 | cenobamate 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283507 | cenobamate 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2283508 | cenobamate 150 MG [Xcopri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2283509 | XCOPRI 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2283509 | XCOPRI 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283509 | XCOPRI 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283510 | cenobamate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2283511 | cenobamate 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283511 | cenobamate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2283512 | cenobamate 200 MG [Xcopri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2283513 | XCOPRI 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2283513 | XCOPRI 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283513 | XCOPRI 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283514 | cenobamate 50 MG Oral Tablet (28) / cenobamate 200 MG Oral Tablet (28) Maintenance Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2283514 | cenobamate 50 MG Oral Tablet (28) / cenobamate 200 MG Oral Tablet (28) Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283514 | cenobamate 50 MG Oral Tablet (28) / cenobamate 200 MG Oral Tablet (28) Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283515 | XCOPRI 250 MG Maintenance Pack - 50 MG (28), 200 MG (28) 56 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2283515 | XCOPRI 250 MG Maintenance Pack - 50 MG (28), 200 MG (28) 56 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283515 | XCOPRI 250 MG Maintenance Pack - 50 MG (28), 200 MG (28) 56 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283517 | cenobamate 150 MG Oral Tablet (28) / cenobamate 200 MG Oral Tablet (28) Maintenance Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2283517 | cenobamate 150 MG Oral Tablet (28) / cenobamate 200 MG Oral Tablet (28) Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283517 | cenobamate 150 MG Oral Tablet (28) / cenobamate 200 MG Oral Tablet (28) Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283518 | XCOPRI 350 MG Maintenance Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2283518 | XCOPRI 350 MG Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283518 | XCOPRI 350 MG Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283519 | cenobamate 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2283520 | cenobamate 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283520 | cenobamate 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2283521 | cenobamate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2283522 | cenobamate 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283522 | cenobamate 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2283523 | cenobamate 12.5 MG Oral Tablet (14) / cenobamate 25 MG Oral Tablet (14) Titration Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2283523 | cenobamate 12.5 MG Oral Tablet (14) / cenobamate 25 MG Oral Tablet (14) Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283523 | cenobamate 12.5 MG Oral Tablet (14) / cenobamate 25 MG Oral Tablet (14) Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283524 | cenobamate 12.5 MG [Xcopri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2283525 | XCOPRI 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2283525 | XCOPRI 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283525 | XCOPRI 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283526 | cenobamate 25 MG [Xcopri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2283527 | XCOPRI 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2283527 | XCOPRI 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283527 | XCOPRI 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283529 | dobutamine (as dobutamine HCl) 12.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283529 | dobutamine (as dobutamine HCl) 12.5 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283529 | dobutamine (as dobutamine HCl) 12.5 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 2283529 | dobutamine (as dobutamine HCl) 12.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283529 | dobutamine (as dobutamine HCl) 12.5 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283529 | dobutamine (as dobutamine HCl) 12.5 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2283530 | Dobutrex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2283531 | DOBUTamine 12.5 MG/ML [Dobutrex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2283531 | DOBUTamine 12.5 MG/ML [Dobutrex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283532 | DOBUTamine Injectable Solution [Dobutrex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2283532 | DOBUTamine Injectable Solution [Dobutrex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283533 | Dobutrex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2283534 | dobutamine 12.5 MG/ML Injectable Solution [Dobutrex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2283534 | dobutamine 12.5 MG/ML Injectable Solution [Dobutrex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283534 | dobutamine 12.5 MG/ML Injectable Solution [Dobutrex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283535 | cenobamate 50 MG Oral Tablet (14) / cenobamate 100 MG Oral Tablet (14) Titration Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2283535 | cenobamate 50 MG Oral Tablet (14) / cenobamate 100 MG Oral Tablet (14) Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283535 | cenobamate 50 MG Oral Tablet (14) / cenobamate 100 MG Oral Tablet (14) Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283536 | XCOPRI Titration Pack - 50 MG (14), 100 MG (14) 28 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2283536 | XCOPRI Titration Pack - 50 MG (14), 100 MG (14) 28 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283536 | XCOPRI Titration Pack - 50 MG (14), 100 MG (14) 28 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283538 | XCOPRI Titration Pack - 12.5 MG (14), 25 MG (14) 28 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2283538 | XCOPRI Titration Pack - 12.5 MG (14), 25 MG (14) 28 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283538 | XCOPRI Titration Pack - 12.5 MG (14), 25 MG (14) 28 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283539 | cenobamate 150 MG Oral Tablet (14) / cenobamate 200 MG Oral Tablet (14) Titration Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2283539 | cenobamate 150 MG Oral Tablet (14) / cenobamate 200 MG Oral Tablet (14) Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283539 | cenobamate 150 MG Oral Tablet (14) / cenobamate 200 MG Oral Tablet (14) Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283540 | XCOPRI Titration Pack - 150 MG (14), 200 MG (14) 28 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2283540 | XCOPRI Titration Pack - 150 MG (14), 200 MG (14) 28 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283540 | XCOPRI Titration Pack - 150 MG (14), 200 MG (14) 28 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283542 | ePHEDrine HCl 0.5 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2283542 | ePHEDrine HCl 0.5 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283542 | ePHEDrine HCl 0.5 % Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283542 | ePHEDrine HCl 0.5 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283542 | ePHEDrine HCl 0.5 % Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2283545 | cholecalciferol 0.095 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2283546 | cholecalciferol 0.095 MG / folic acid 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283546 | cholecalciferol 0.095 MG / folic acid 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2283546 | cholecalciferol 0.095 MG / folic acid 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2283546 | cholecalciferol 0.095 MG / folic acid 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2283603 | ethanol 0.58 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2283604 | ethanol 58 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283604 | ethanol 58 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2283604 | ethanol 58 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283613 | bronopol 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2283614 | bronopol 0.25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2283614 | bronopol 0.25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283614 | bronopol 0.25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2283757 | red pine whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283757 | red pine whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2283757 | red pine whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2283758 | 1-(3-amino-4-hydroxyphenyl)-2-((2-(4-methoxyphenyl)-1-methylethyl)amino)ethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2283759 | bis-ethoxydiglycol cyclohexane 1,4-dicarboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2284 | cetrimides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2284072 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Vetuss HC Syrup] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284072 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Vetuss HC Syrup] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2284076 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Statuss Green] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284076 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Statuss Green] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2284078 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Q-Tuss with Hydrocodone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284078 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Q-Tuss with Hydrocodone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2284080 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Rutuss with Hydrocodone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284080 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Rutuss with Hydrocodone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2284082 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Rolatuss with Hydrocodone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284082 | hydrocodone bitartrate 0.34 MG/ML / pheniramine maleate 0.66 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenylpropanolamine hydrochloride 0.66 MG/ML / pyrilamine maleate 0.66 MG/ML [Rolatuss with Hydrocodone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2284101 | palbociclib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284102 | palbociclib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284102 | palbociclib 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2284102 | palbociclib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284102 | palbociclib 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2284103 | palbociclib Oral Tablet [Ibrance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284104 | Ibrance 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284104 | Ibrance 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284104 | Ibrance 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2284105 | palbociclib 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284105 | palbociclib 125 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2284105 | palbociclib 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284105 | palbociclib 125 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2284106 | Ibrance 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284106 | Ibrance 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284106 | Ibrance 125 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2284107 | palbociclib 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284107 | palbociclib 75 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2284107 | palbociclib 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284107 | palbociclib 75 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2284108 | Ibrance 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284108 | Ibrance 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284108 | Ibrance 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2284113 | chlordiazepoxide hydrochloride 5 MG / methscopolamine nitrate 2.5 MG [Librax Reformulated Aug 2006] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284113 | chlordiazepoxide hydrochloride 5 MG / methscopolamine nitrate 2.5 MG [Librax Reformulated Aug 2006] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2284115 | pheniramine maleate 1.26 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2284116 | pyrilamine maleate 1.26 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2284119 | pheniramine maleate 0.8 MG/ML / phenyltoloxamine citrate 0.8 MG/ML / pyrilamine maleate 0.8 MG/ML [Poly-Histine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284121 | pheniramine maleate 0.8 MG/ML / phenyltoloxamine citrate 0.8 MG/ML / pyrilamine maleate 0.8 MG/ML [Liqui-Histine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284124 | pheniramine maleate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2284125 | phenylpropanolamine hydrochloride 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2284127 | pheniramine maleate 10 MG/ML / phenylpropanolamine hydrochloride 20 MG/ML / pyrilamine maleate 10 MG/ML [Triactin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284131 | pheniramine maleate 10 MG/ML / phenylpropanolamine hydrochloride 20 MG/ML / pyrilamine maleate 10 MG/ML [Tri-P Oral Infant Drops] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284137 | pheniramine maleate 10 MG/ML / phenylpropanolamine hydrochloride 20 MG/ML / pyrilamine maleate 10 MG/ML [Liqui-Minic Infant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284146 | pyrilamine tannate 2.4 MG/ML [Pyrlex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284147 | ascorbic acid Powder for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284154 | carbetapentane tannate 4.5 MG/ML / pyrilamine tannate 2.4 MG/ML [Pyrlex CB] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284158 | ascorbic acid / cholecalciferol / ferrous sulfate / vitamin A Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2284159 | ascorbic acid / cholecalciferol / ferrous sulfate / vitamin A Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2284160 | ascorbic acid / cholecalciferol / ferrous sulfate / vitamin A Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2284161 | ascorbic acid / cholecalciferol / ferrous sulfate / vitamin A | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2284163 | ascorbic acid 35 MG/ML / cholecalciferol 0.01 MG/ML / ferrous sulfate 50 MG/ML / vitamin A 0.45 MG/ML [Tri-Vi-Sol with Iron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284164 | ascorbic acid / cholecalciferol / ferrous sulfate / vitamin A Oral Solution [Tri-Vi-Sol with Iron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2284167 | Sydney golden wattle pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2284169 | ergocalciferol 0.01 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284171 | cholecalciferol 0.075 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284173 | ergocalciferol 0.05 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284175 | cholecalciferol 0.35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284177 | tag alder pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284179 | ergocalciferol 0.0625 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284181 | cholecalciferol 0.625 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284183 | cholecalciferol 0.625 MG [Decara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2284185 | white ash pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284187 | bahia grass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284190 | beech pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2284192 | Bermuda grass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284194 | cholecalciferol 0.375 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284196 | cholecalciferol 0.025 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284230 | amisulpride 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284231 | amisulpride Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284232 | amisulpride 5 MG in 2 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284232 | amisulpride 5 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284232 | amisulpride 5 MG in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284232 | amisulpride 5 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284233 | Barhemsys | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2284234 | amisulpride 2.5 MG/ML [Barhemsys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2284235 | amisulpride Injection [Barhemsys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284236 | Barhemsys Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2284237 | Barhemsys 5 MG in 2 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2284237 | Barhemsys 5 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284237 | Barhemsys 5 MG in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284237 | Barhemsys 5 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284238 | amisulpride 2.5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2284239 | amisulpride 2.5 MG/ML Injection [Barhemsys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2284239 | amisulpride 2.5 MG/ML Injection [Barhemsys] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2284244 | iodine 2 % / sodium iodide 2.4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284244 | iodine 2 % / sodium iodide 2.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284244 | iodine 2 % / sodium iodide 2.4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284285 | inulin 5000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284286 | inulin 5 GM / vitamin D3 1000 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284286 | inulin 5 GM / vitamin D3 1000 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284286 | inulin 5 GM / vitamin D3 1000 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284287 | Vanilla planifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2284289 | Inhalation Spray | Dose Form (DF) | YES | |
| RxCUI: 2284290 | Delayed Release Oral Granules | Dose Form (DF) | YES | |
| RxCUI: 2284291 | Ananas comosus extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2284291 | Ananas comosus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2284296 | Fendique | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2284297 | phendimetrazine tartrate 105 MG [Fendique] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2284298 | phendimetrazine Extended Release Oral Capsule [Fendique] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2284299 | Fendique Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2284300 | Fendique Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2284301 | Fendique 105 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2284301 | Fendique 105 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2284301 | Fendique 105 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2284301 | Fendique 105 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2284302 | phendimetrazine tartrate 105 MG Extended Release Oral Capsule [Fendique] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2284302 | phendimetrazine tartrate 105 MG Extended Release Oral Capsule [Fendique] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2284345 | ethanol 0.656 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2284346 | ethanol 65.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2284346 | ethanol 65.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2284346 | ethanol 65.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2284502 | irinotecan Injection [Onivyde] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284504 | DOXOrubicin Injection [LipoDox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2284504 | DOXOrubicin Injection [LipoDox] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2284505 | vinCRIStine Injection [Marqibo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284505 | vinCRIStine Injection [Marqibo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2284506 | DOXOrubicin Injection [Doxil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284506 | DOXOrubicin Injection [Doxil] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2284507 | cysteamine 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284508 | cysteamine Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2284509 | cysteamine Delayed Release Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284510 | cysteamine 300 MG Delayed Release Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284510 | cysteamine 300 MG Delayed Release Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284510 | cysteamine 300 MG Delayed Release Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284511 | cysteamine 300 MG [Procysbi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2284512 | cysteamine Delayed Release Oral Granules [Procysbi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284513 | Procysbi Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2284514 | PROCYSBI 300 MG Delayed Release Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2284514 | PROCYSBI 300 MG Delayed Release Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284514 | PROCYSBI 300 MG Delayed Release Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284515 | cysteamine 75 MG Delayed Release Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284515 | cysteamine 75 MG Delayed Release Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284515 | cysteamine 75 MG Delayed Release Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284516 | PROCYSBI 75 MG Delayed Release Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2284516 | PROCYSBI 75 MG Delayed Release Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284516 | PROCYSBI 75 MG Delayed Release Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284602 | lactitol 10000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284603 | lactitol Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2284604 | lactitol Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284605 | lactitol 10000 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284605 | lactitol 10000 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284606 | Pizensy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2284607 | lactitol 10000 MG [Pizensy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2284608 | lactitol Powder for Oral Solution [Pizensy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284609 | Pizensy Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2284610 | Pizensy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2284611 | Pizensy 10000 MG Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2284611 | Pizensy 10000 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284611 | Pizensy 10000 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2284612 | olodaterol Inhalation Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284614 | olodaterol Inhalation Spray [Striverdi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284620 | tiotropium Inhalation Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284622 | tiotropium Inhalation Spray [Spiriva] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284636 | albuterol / ipratropium Inhalation Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284638 | albuterol / ipratropium Inhalation Spray [Combivent] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284646 | olodaterol / tiotropium Inhalation Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284648 | olodaterol / tiotropium Inhalation Spray [Stiolto] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2284656 | Walnut oil | Designated preferred name (PT) | NO | |
| RxCUI: 2284656 | Walnut oil | Full form of descriptor (FN) | NO | |
| RxCUI: 2284659 | petrolatum 390 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284661 | lidocaine 50 MG/ML / mineral oil 170 MG/ML / petrolatum 390 MG/ML / phenylephrine hydrochloride 2.5 MG/ML [RectiCare Advance Cream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2284708 | Food | Designated preferred name (PT) | NO | |
| RxCUI: 2284708 | Food | Full form of descriptor (FN) | NO | |
| RxCUI: 2284710 | patisiran sodium lipid complex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2284711 | patisiran lipid complex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2284712 | patisiran lipid complex 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284714 | patisiran lipid complex 2 MG/ML [Onpattro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2284718 | remdesivir | Full form of descriptor (FN) | YES | |
| RxCUI: 2284718 | remdesivir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2284718 | remdesivir | Designated preferred name (PT) | YES | |
| RxCUI: 2284718 | remdesivir | Full form of descriptor (FN) | YES | |
| RxCUI: 2284718 | remdesivir | Designated preferred name (PT) | YES | |
| RxCUI: 228476 | gatifloxacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 228476 | gatifloxacin | Designated preferred name (PT) | YES | |
| RxCUI: 228476 | gatifloxacin | Full form of descriptor (FN) | YES | |
| RxCUI: 228476 | gatifloxacin | Designated preferred name (PT) | YES | |
| RxCUI: 228476 | gatifloxacin | Full form of descriptor (FN) | YES | |
| RxCUI: 2284957 | remdesivir 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2284958 | remdesivir Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2284958 | remdesivir Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2284958 | remdesivir Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2284959 | remdesivir Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2284960 | remdesivir 100 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 2284960 | remdesivir 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2284960 | remdesivir 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2284960 | remdesivir 100 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 228498 | Aquaporin-6 | Designated preferred name (PT) | NO | |
| RxCUI: 228498 | Aquaporin-6 | Full form of descriptor (FN) | NO | |
| RxCUI: 228530 | Rapacuronium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 228530 | Rapacuronium bromide | Designated preferred name (PT) | NO | |
| RxCUI: 228530 | Rapacuronium bromide | Full form of descriptor (FN) | NO | |
| RxCUI: 2285323 | glycereth-20 cocoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2285325 | Sus scrofa intestinal mucosa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2285326 | polyglyceryl-2 oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2285327 | propylene glycol 2-myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2285328 | bilirubin preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2285329 | carbomer copolymer type C (allyl pentaerythritol crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2285402 | OXT-101 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2285402 | OXT-101 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2285502 | hypochlorous acid 0.46 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2285503 | hypochlorous acid 0.046 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2285503 | hypochlorous acid 0.046 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2285503 | hypochlorous acid 0.046 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2285607 | isopropyl alcohol 75 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2285607 | isopropyl alcohol 75 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2285607 | isopropyl alcohol 75 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2285802 | amphotericin B Injection [Abelcet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2285803 | amikacin Inhalation Suspension [Arikayce] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2285804 | amikacin Inhalation Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2285805 | bupivacaine Injection [Exparel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2285805 | bupivacaine Injection [Exparel] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2285806 | cytarabine / daunorubicin Injection [Vyxeos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2285806 | cytarabine / daunorubicin Injection [Vyxeos] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2285807 | cytarabine / daunorubicin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2285807 | cytarabine / daunorubicin Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2285808 | DAUNOrubicin Injection [DaunoXome] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2285808 | DAUNOrubicin Injection [DaunoXome] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2285809 | amphotericin B Injection [AmBisome] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2285810 | cytarabine Injection [DepoCyt] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2285811 | amphotericin B Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2285812 | amikacin Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2285813 | cytarabine / daunorubicin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2285813 | cytarabine / daunorubicin Injectable Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2285813 | cytarabine / daunorubicin Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2285813 | cytarabine / daunorubicin Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2285902 | Product containing rabbit anti-human T-lymphocyte globulin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2285902 | Product containing rabbit anti-human T-lymphocyte globulin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2286 | Product containing cetylpyridinium (medicinal product) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2286 | Product containing cetylpyridinium (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2286 | Product containing cetylpyridinium (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2286 | Product containing cetylpyridinium (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2286 | Product containing cetylpyridinium (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 22862 | Dibrompropamidine isetionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 22862 | Dibrompropamidine isetionate | Designated preferred name (PT) | NO | |
| RxCUI: 22862 | Dibrompropamidine isetionate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22862 | Dibrompropamidine isetionate | Full form of descriptor (FN) | NO | |
| RxCUI: 2286238 | lactoferrin (synthetic human) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286239 | sodium cholate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286249 | 2-carboxyethyl acrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286250 | 2-chloro-4,5-dimethylphenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286251 | benzoic acid 2-(2,4,6-trichlorophenyl)hydrazide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2286252 | osilodrostat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2286252 | osilodrostat | Designated preferred name (PT) | YES | |
| RxCUI: 2286252 | osilodrostat | Full form of descriptor (FN) | YES | |
| RxCUI: 2286252 | osilodrostat | Designated preferred name (PT) | YES | |
| RxCUI: 2286252 | osilodrostat | Full form of descriptor (FN) | YES | |
| RxCUI: 2286253 | osilodrostat phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2286253 | osilodrostat phosphate | Designated preferred name (PT) | YES | |
| RxCUI: 2286253 | osilodrostat phosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 2286254 | potassium olivate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286255 | sodium allylsulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286256 | Hemady | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2286257 | dexamethasone 20 MG [Hemady] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2286257 | dexamethasone 20 MG [Hemady] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2286258 | dexamethasone Oral Tablet [Hemady] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2286258 | dexamethasone Oral Tablet [Hemady] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2286259 | Hemady Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286260 | Hemady Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286261 | HEMADY 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2286261 | HEMADY 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2286261 | HEMADY 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286261 | HEMADY 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286262 | ethanol 70 % / benzalkonium chloride 0.13 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286262 | ethanol 70 % / benzalkonium chloride 0.13 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286262 | ethanol 70 % / benzalkonium chloride 0.13 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286263 | ethanol 0.653 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2286264 | ethanol 65.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286264 | ethanol 65.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286264 | ethanol 65.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286271 | osilodrostat 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2286272 | osilodrostat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2286272 | osilodrostat Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2286272 | osilodrostat Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2286273 | osilodrostat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2286274 | osilodrostat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2286275 | osilodrostat 1 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2286275 | osilodrostat 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286275 | osilodrostat 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286275 | osilodrostat 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2286275 | osilodrostat 1 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2286276 | Isturisa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2286277 | osilodrostat 1 MG [Isturisa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2286278 | osilodrostat Oral Tablet [Isturisa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2286279 | Isturisa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286280 | Isturisa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286281 | Isturisa 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286281 | Isturisa 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286281 | Isturisa 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286281 | Isturisa 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2286282 | osilodrostat 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2286283 | osilodrostat 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2286283 | osilodrostat 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286283 | osilodrostat 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286283 | osilodrostat 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2286283 | osilodrostat 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2286284 | osilodrostat 10 MG [Isturisa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2286285 | Isturisa 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286285 | Isturisa 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286285 | Isturisa 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286285 | Isturisa 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2286287 | osilodrostat 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2286288 | osilodrostat 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2286288 | osilodrostat 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286288 | osilodrostat 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286288 | osilodrostat 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2286288 | osilodrostat 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2286289 | osilodrostat 5 MG [Isturisa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2286290 | Isturisa 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286290 | Isturisa 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286290 | Isturisa 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286290 | Isturisa 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2286291 | ethanol 68 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286291 | ethanol 68 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286291 | ethanol 68 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286294 | salicylic acid 2 % / sulfur 5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286294 | salicylic acid 2 % / sulfur 5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286294 | salicylic acid 2 % / sulfur 5 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286295 | ethanol 75 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286295 | ethanol 75 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286295 | ethanol 75 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22865 | Dibrompropamidine | Designated preferred name (PT) | NO | |
| RxCUI: 22865 | Dibrompropamidine | Designated preferred name (PT) | NO | |
| RxCUI: 22865 | Dibrompropamidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 22865 | Dibrompropamidine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22865 | Dibrompropamidine | Full form of descriptor (FN) | NO | |
| RxCUI: 22865 | Dibrompropamidine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22865 | Dibrompropamidine | Full form of descriptor (FN) | NO | |
| RxCUI: 228655 | Agenerase | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 228656 | Amprenavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 228656 | Amprenavir | Designated preferred name (PT) | YES | |
| RxCUI: 228656 | Amprenavir | Full form of descriptor (FN) | YES | |
| RxCUI: 228656 | Amprenavir | Designated preferred name (PT) | YES | |
| RxCUI: 228656 | Amprenavir | Full form of descriptor (FN) | YES | |
| RxCUI: 2286574 | (ethylenedinitrilo)tetraacetonitrile | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286575 | Melia azedarach leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286577 | bacitracin A methylenedisalicylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2286585 | Nouress | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2286586 | cysteine hydrochloride 50 MG/ML [Nouress] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2286587 | cysteine Injection [Nouress] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2286588 | Nouress Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286589 | NOURESS 500 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2286589 | NOURESS 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286589 | NOURESS 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286589 | NOURESS 500 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286590 | cysteine hydrochloride 50 MG/ML Injection [Nouress] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2286590 | cysteine hydrochloride 50 MG/ML Injection [Nouress] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286591 | pheniramine maleate 17.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2286592 | pheniramine maleate 17.5 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286592 | pheniramine maleate 17.5 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2286593 | Alahist D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2286594 | pheniramine maleate 17.5 MG / phenylephrine hydrochloride 10 MG [Alahist D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2286595 | pheniramine / phenylephrine Oral Tablet [Alahist D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2286596 | Alahist D Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286597 | Alahist D Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286598 | ALAHIST D 17.5 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286598 | ALAHIST D 17.5 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286598 | ALAHIST D 17.5 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2286599 | bimatoprost 0.01 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2286600 | bimatoprost Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2286601 | bimatoprost Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2286602 | bimatoprost 10 MCG Intracameral Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2286602 | bimatoprost 10 MCG Intracameral Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286602 | bimatoprost 10 MCG Intracameral Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286603 | Durysta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2286604 | bimatoprost 0.01 MG [Durysta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2286605 | bimatoprost Drug Implant [Durysta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2286606 | Durysta Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286607 | DURYSTA 10 MCG Intracameral Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2286607 | DURYSTA 10 MCG Intracameral Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286607 | DURYSTA 10 MCG Intracameral Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286610 | Pirnuo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2286611 | mupirocin 20 MG/ML [Pirnuo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2286612 | mupirocin Topical Cream [Pirnuo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2286613 | Pirnuo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2286614 | PIRNUO 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2286614 | PIRNUO 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2286614 | PIRNUO 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286614 | PIRNUO 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2286802 | 1,3-butyleneglycol dimethacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286803 | PEG-7 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2286804 | anhydromethylenecitric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286805 | bis-oleamido isopropyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2286806 | wild thyme extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2286985 | ethanol 62.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286985 | ethanol 62.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286985 | ethanol 62.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286986 | ethanol 0.73 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2286987 | ethanol 73 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286987 | ethanol 73 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286987 | ethanol 73 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286988 | ethanol 73 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286988 | ethanol 73 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286988 | ethanol 73 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286989 | colloidal oatmeal 0.06 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2286990 | mineral oil 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2286991 | colloidal oatmeal / mineral oil Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2286992 | colloidal oatmeal / mineral oil Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2286993 | colloidal oatmeal 0.006 % / mineral oil 30 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2286993 | colloidal oatmeal 0.006 % / mineral oil 30 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2286993 | colloidal oatmeal 0.006 % / mineral oil 30 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2286994 | levoisomethadone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2287 | Cetylpyridinium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2287 | Cetylpyridinium chloride | Designated preferred name (PT) | YES | |
| RxCUI: 2287 | Cetylpyridinium chloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2287004 | fluorescein sodium 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2287005 | benoxinate HCl 0.4 % / fluorescein sodium 0.3 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287005 | benoxinate HCl 0.4 % / fluorescein sodium 0.3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287005 | benoxinate HCl 0.4 % / fluorescein sodium 0.3 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2287034 | isopropyl alcohol 72 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287034 | isopropyl alcohol 72 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287034 | isopropyl alcohol 72 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287038 | isopropyl alcohol 0.072 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2287039 | ethanol / isopropyl alcohol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2287040 | ethanol 69 % / isopropyl alcohol 7.2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287040 | ethanol 69 % / isopropyl alcohol 7.2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287040 | ethanol 69 % / isopropyl alcohol 7.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287153 | triphenylmethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287154 | Citrus aurantium leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287155 | ethanol 0.83 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2287156 | ethanol 83 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287156 | ethanol 83 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287156 | ethanol 83 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287157 | ethanol 83 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287157 | ethanol 83 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287157 | ethanol 83 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287158 | immunoglobulin G, human 20 % in 20 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2287158 | immunoglobulin G, human 20 % in 20 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287158 | immunoglobulin G, human 20 % in 20 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287159 | Hizentra 20 % in 20 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287159 | Hizentra 20 % in 20 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2287159 | Hizentra 20 % in 20 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287159 | Hizentra 20 % in 20 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287160 | isopropyl alcohol 75 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287160 | isopropyl alcohol 75 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287160 | isopropyl alcohol 75 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287160 | isopropyl alcohol 75 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287161 | ethanol 50 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287161 | ethanol 50 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287161 | ethanol 50 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287161 | ethanol 50 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287162 | capsaicin 0.00083 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2287163 | capsaicin 0.83 MG / menthol 30 MG per 1 GM Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287163 | capsaicin 0.83 MG / menthol 30 MG per 1 GM Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287163 | capsaicin 0.83 MG / menthol 30 MG per 1 GM Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287163 | capsaicin 0.83 MG / menthol 30 MG per 1 GM Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228750 | Moxifloxacin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 228750 | Moxifloxacin hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 228750 | Moxifloxacin hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2287547 | Aleurites moluccanus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287548 | Equisetum fluviatile whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287549 | Macadamia ternifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287550 | triethanolamine phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2287551 | monomethyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287556 | camphor 2 % / lidocaine 2.5 % / methyl salicylate 4 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2287556 | camphor 2 % / lidocaine 2.5 % / methyl salicylate 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287556 | camphor 2 % / lidocaine 2.5 % / methyl salicylate 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287560 | sodium ethasulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287730 | Angelica gigas extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287730 | Angelica gigas extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287731 | butanediol (mixed isomers) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2287732 | dimethicone PEG-8 isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287733 | fusel oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287734 | Ganoderma lucidum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287734 | Ganoderma lucidum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2287736 | 1-O-tetradecylglycerol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2287737 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287737 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287737 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287737 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287738 | acetaminophen / diphenhydramine / phenylephrine Effervescent Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2287738 | acetaminophen / diphenhydramine / phenylephrine Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2287739 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287739 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287739 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2287739 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287739 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2287739 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287739 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2287754 | ferric pyrophosphate citrate 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2287755 | ferric pyrophosphate citrate (as iron) 6.75 MG in 4.5 mL hemodialysis Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2287755 | ferric pyrophosphate citrate (as iron) 6.75 MG in 4.5 mL hemodialysis Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287755 | ferric pyrophosphate citrate (as iron) 6.75 MG in 4.5 mL hemodialysis Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287756 | ferric pyrophosphate citrate 1.5 MG/ML [Triferic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2287757 | Triferic (iron) 6.75 MG in 4.5 mL hemodialysis Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2287757 | Triferic (iron) 6.75 MG in 4.5 mL hemodialysis Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287757 | Triferic (iron) 6.75 MG in 4.5 mL hemodialysis Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287757 | Triferic (iron) 6.75 MG in 4.5 mL hemodialysis Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287758 | ferric pyrophosphate citrate 1.5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287759 | ferric pyrophosphate citrate 1.5 MG/ML Injection [Triferic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2287759 | ferric pyrophosphate citrate 1.5 MG/ML Injection [Triferic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287760 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2287760 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2287760 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287760 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287760 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2287762 | ethanol 74 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287762 | ethanol 74 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287762 | ethanol 74 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287763 | ethanol 69 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287763 | ethanol 69 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287763 | ethanol 69 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287765 | ethanol 73 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287765 | ethanol 73 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287765 | ethanol 73 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228783 | frovatriptan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 228783 | frovatriptan | Designated preferred name (PT) | YES | |
| RxCUI: 228783 | frovatriptan | Full form of descriptor (FN) | YES | |
| RxCUI: 228783 | frovatriptan | Designated preferred name (PT) | YES | |
| RxCUI: 228783 | frovatriptan | Full form of descriptor (FN) | YES | |
| RxCUI: 228790 | Dutasteride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 228790 | Dutasteride | Designated preferred name (PT) | YES | |
| RxCUI: 228790 | Dutasteride | Full form of descriptor (FN) | YES | |
| RxCUI: 228790 | Dutasteride | Designated preferred name (PT) | YES | |
| RxCUI: 228790 | Dutasteride | Full form of descriptor (FN) | YES | |
| RxCUI: 2287902 | fremanezumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2287903 | fremanezumab-vfrm 225 MG in 1.5 mL Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2287903 | fremanezumab-vfrm 225 MG in 1.5 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287903 | fremanezumab-vfrm 225 MG in 1.5 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287904 | fremanezumab Auto-Injector [Ajovy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2287905 | AJOVY 225 MG in 1.5 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287905 | AJOVY 225 MG in 1.5 mL Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2287905 | AJOVY 225 MG in 1.5 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2287905 | AJOVY 225 MG in 1.5 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2287906 | fremanezumab-vfrm 150 MG/mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287906 | fremanezumab-vfrm 150 MG/mL Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287907 | Ajovy 150 MG/mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287907 | Ajovy 150 MG/mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2287907 | Ajovy 150 MG/mL Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2287958 | isopropyl alcohol 0.65 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2287959 | isopropyl alcohol 65 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2287959 | isopropyl alcohol 65 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2287959 | isopropyl alcohol 65 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288 | Cevadine | Designated preferred name (PT) | NO | |
| RxCUI: 2288 | Cevadine | Full form of descriptor (FN) | NO | |
| RxCUI: 228806 | Pro brain natriuretic peptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228806 | Pro brain natriuretic peptide | Designated preferred name (PT) | NO | |
| RxCUI: 228806 | Pro brain natriuretic peptide | Full form of descriptor (FN) | NO | |
| RxCUI: 228806 | Pro brain natriuretic peptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228806 | Pro brain natriuretic peptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228806 | Pro brain natriuretic peptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228806 | Pro brain natriuretic peptide | Designated preferred name (PT) | NO | |
| RxCUI: 228806 | Pro brain natriuretic peptide | Full form of descriptor (FN) | NO | |
| RxCUI: 2288155 | peoniflorin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288156 | Aloe arborescens flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288171 | benzalkonium chloride 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2288172 | benzalkonium chloride 0.25 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2288172 | benzalkonium chloride 0.25 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288172 | benzalkonium chloride 0.25 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2288173 | 5-norbornene-2-methylolacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288179 | pride of India leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288179 | pride of India leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288209 | methyltriethanolammonium methosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288210 | PEG-10 lanolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288215 | calcium sodium phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2288235 | ozanimod hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2288235 | ozanimod hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 2288235 | ozanimod hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2288236 | ozanimod | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2288236 | ozanimod | Designated preferred name (PT) | YES | |
| RxCUI: 2288236 | ozanimod | Full form of descriptor (FN) | YES | |
| RxCUI: 2288236 | ozanimod | Designated preferred name (PT) | YES | |
| RxCUI: 2288236 | ozanimod | Full form of descriptor (FN) | YES | |
| RxCUI: 2288238 | ethanol 0.733 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2288239 | ethanol 73.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2288239 | ethanol 73.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2288239 | ethanol 73.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228833 | Gadolinium chelate diethylenetriamine pentaacetic acid bismethoxyethylamide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228833 | Gadolinium chelate diethylenetriamine pentaacetic acid bismethoxyethylamide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 228833 | Gadolinium chelate diethylenetriamine pentaacetic acid bismethoxyethylamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 228833 | Gadolinium chelate diethylenetriamine pentaacetic acid bismethoxyethylamide | Designated preferred name (PT) | NO | |
| RxCUI: 228833 | Gadolinium chelate diethylenetriamine pentaacetic acid bismethoxyethylamide | Full form of descriptor (FN) | NO | |
| RxCUI: 228833 | Gadolinium chelate diethylenetriamine pentaacetic acid bismethoxyethylamide | Designated preferred name (PT) | NO | |
| RxCUI: 228833 | Gadolinium chelate diethylenetriamine pentaacetic acid bismethoxyethylamide | Full form of descriptor (FN) | NO | |
| RxCUI: 2288402 | ozanimod 0.92 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2288403 | ozanimod Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2288403 | ozanimod Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2288403 | ozanimod Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2288404 | ozanimod Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2288405 | ozanimod Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2288406 | ozanimod 0.92 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2288406 | ozanimod 0.92 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288406 | ozanimod 0.92 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288406 | ozanimod 0.92 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2288406 | ozanimod 0.92 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2288407 | Zeposia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2288408 | ozanimod 0.92 MG [Zeposia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2288409 | ozanimod Oral Capsule [Zeposia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2288410 | Zeposia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2288411 | Zeposia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2288412 | ZEPOSIA 0.92 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2288412 | ZEPOSIA 0.92 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288412 | ZEPOSIA 0.92 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288413 | ozanimod 0.23 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2288414 | ozanimod 0.23 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2288414 | ozanimod 0.23 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288414 | ozanimod 0.23 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288414 | ozanimod 0.23 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2288414 | ozanimod 0.23 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2288415 | ozanimod 0.23 MG [Zeposia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2288416 | ZEPOSIA 0.23 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2288416 | ZEPOSIA 0.23 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288416 | ZEPOSIA 0.23 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288417 | ozanimod 0.46 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2288418 | ozanimod 0.46 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2288418 | ozanimod 0.46 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288418 | ozanimod 0.46 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288418 | ozanimod 0.46 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2288418 | ozanimod 0.46 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2288419 | ozanimod 0.46 MG [Zeposia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2288420 | ZEPOSIA 0.46 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2288420 | ZEPOSIA 0.46 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288420 | ZEPOSIA 0.46 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288423 | Citrus junos fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288424 | lemborexant 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2288425 | lemborexant 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288425 | lemborexant 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2288426 | lemborexant 10 MG [Dayvigo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2288427 | DAYVIGO 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288427 | DAYVIGO 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288427 | DAYVIGO 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2288428 | Pinus densiflora whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288429 | miconazole 4 % Vaginal Cream 3-Day Applicator Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2288429 | miconazole 4 % Vaginal Cream 3-Day Applicator Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288429 | miconazole 4 % Vaginal Cream 3-Day Applicator Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2288430 | ozanimod 37-Day Starter Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2288430 | ozanimod 37-Day Starter Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288430 | ozanimod 37-Day Starter Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288431 | ZEPOSIA 37-Day Starter Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2288431 | ZEPOSIA 37-Day Starter Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288431 | ZEPOSIA 37-Day Starter Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288432 | ozanimod 7-Day Starter Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2288432 | ozanimod 7-Day Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288432 | ozanimod 7-Day Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288433 | ZEPOSIA 7-Day Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2288433 | ZEPOSIA 7-Day Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288433 | ZEPOSIA 7-Day Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288434 | ethanol 54.7 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2288434 | ethanol 54.7 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2288434 | ethanol 54.7 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288435 | ethanol 69 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2288435 | ethanol 69 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2288435 | ethanol 69 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288438 | ethanol 83 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2288438 | ethanol 83 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2288438 | ethanol 83 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288439 | hypochlorous acid 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2288440 | hypochlorous acid 0.003 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2288440 | hypochlorous acid 0.003 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288440 | hypochlorous acid 0.003 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2288443 | cocoa butter 0.887 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2288444 | cocoa butter 88.7 % / phenylephrine HCl 0.25 % Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2288444 | cocoa butter 88.7 % / phenylephrine HCl 0.25 % Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288444 | cocoa butter 88.7 % / phenylephrine HCl 0.25 % Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288811 | 2-(2-ethylhexyloxy)ethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288812 | dichlorodicyanobenzoquinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2288812 | dichlorodicyanobenzoquinone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288813 | velpatasvir 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2288814 | sofosbuvir 200 MG / velpatasvir 50 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2288814 | sofosbuvir 200 MG / velpatasvir 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288814 | sofosbuvir 200 MG / velpatasvir 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2288814 | sofosbuvir 200 MG / velpatasvir 50 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2288815 | sofosbuvir 200 MG / velpatasvir 50 MG [Epclusa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2288816 | Epclusa 200 MG / 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288816 | Epclusa 200 MG / 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288816 | Epclusa 200 MG / 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2288821 | benzalkonium chloride 0.66 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2288822 | benzalkonium chloride 0.066 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2288822 | benzalkonium chloride 0.066 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2288822 | benzalkonium chloride 0.066 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2288826 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2288826 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2288826 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2288826 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2288826 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2289003 | 2-((dimethylamino)methyl)-1,3-diphenyl-1-propanol, erythro- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289004 | 2-methyl-4-phenyl-2-butanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289005 | 4-tert-butylcyclohexyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289006 | acetyl cedrene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289007 | acetyl hexamethyl tetralin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289008 | C11-15 pareth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289010 | dimethyl benzyl carbinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289011 | ozone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289012 | polyester-5 (TG-48) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289025 | Chimonanthus praecox flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289027 | allantoin 0.2 % / benzalkonium chloride 0.3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2289027 | allantoin 0.2 % / benzalkonium chloride 0.3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2289027 | allantoin 0.2 % / benzalkonium chloride 0.3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2289028 | chlorhexidine acetate 0.2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2289028 | chlorhexidine acetate 0.2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2289028 | chlorhexidine acetate 0.2 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2289032 | ethanol 0.589 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2289033 | ethanol 58.9 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2289033 | ethanol 58.9 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2289033 | ethanol 58.9 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22892 | Dichloralantipyrine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 22892 | Dichloralantipyrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 22892 | Dichloralantipyrine | Designated preferred name (PT) | YES | |
| RxCUI: 22892 | Dichloralantipyrine | Full form of descriptor (FN) | YES | |
| RxCUI: 22892 | Dichloralantipyrine | Designated preferred name (PT) | YES | |
| RxCUI: 22892 | Dichloralantipyrine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 22892 | Dichloralantipyrine | Full form of descriptor (FN) | YES | |
| RxCUI: 2289215 | Celosia cristata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289216 | Loeselia mexicana top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289218 | polyester (adipic acid, 1,6-hexanediol, neopentyl glycol) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289221 | Eriastrum filifolium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289222 | direct black 19 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289224 | sulfuryl fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289225 | trastuzumab-dttb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2289226 | trastuzumab-dttb 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2289227 | trastuzumab-dttb 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289227 | trastuzumab-dttb 150 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2289228 | Ontruzant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2289229 | trastuzumab-dttb 150 MG [Ontruzant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2289230 | trastuzumab Injection [Ontruzant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2289231 | Ontruzant Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2289232 | Ontruzant 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289232 | Ontruzant 150 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289232 | Ontruzant 150 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2289233 | trastuzumab-dttb 21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2289234 | trastuzumab-dttb 420 MG in 20 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2289234 | trastuzumab-dttb 420 MG in 20 ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289234 | trastuzumab-dttb 420 MG in 20 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289235 | trastuzumab-dttb 21 MG/ML [Ontruzant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2289236 | trastuzumab Injectable Solution [Ontruzant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2289237 | Ontruzant 420 MG in 20 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289237 | Ontruzant 420 MG in 20 ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289237 | Ontruzant 420 MG in 20 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289237 | Ontruzant 420 MG in 20 ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2289238 | Aller-Cort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2289239 | triamcinolone acetonide 0.055 MG/ACTUAT [Aller-Cort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2289240 | triamcinolone Metered Dose Nasal Spray [Aller-Cort] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2289241 | Aller-Cort Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2289242 | Aller-Cort Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2289243 | Aller-Cort 55 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289243 | Aller-Cort 55 MCG/ACTUAT Metered Dose Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289243 | Aller-Cort 55 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289243 | Aller-Cort 55 MCG/ACTUAT Metered Dose Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2289244 | chrysanthemic acid, (+/-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289380 | selumetinib | Full form of descriptor (FN) | YES | |
| RxCUI: 2289380 | selumetinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2289380 | selumetinib | Designated preferred name (PT) | YES | |
| RxCUI: 2289380 | selumetinib | Full form of descriptor (FN) | YES | |
| RxCUI: 2289380 | selumetinib | Designated preferred name (PT) | YES | |
| RxCUI: 2289402 | ethanol 61 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2289402 | ethanol 61 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2289402 | ethanol 61 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2289406 | ethanol 0.79 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2289407 | ethanol 79 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2289407 | ethanol 79 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2289407 | ethanol 79 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2289408 | Dehydrotestosterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2289408 | Dehydrotestosterone | Designated preferred name (PT) | NO | |
| RxCUI: 2289408 | Dehydrotestosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 2289408 | Dehydrotestosterone | Designated preferred name (PT) | NO | |
| RxCUI: 2289408 | Dehydrotestosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2289408 | Dehydrotestosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 2289409 | Boldenone undecylenate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2289409 | Boldenone undecylenate | Designated preferred name (PT) | NO | |
| RxCUI: 2289409 | Boldenone undecylenate | Full form of descriptor (FN) | NO | |
| RxCUI: 2289410 | romidepsin 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2289410 | romidepsin 5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2289411 | romiDEPsin 10 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2289411 | romiDEPsin 10 MG in 2 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2289411 | romiDEPsin 10 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2289411 | romiDEPsin 10 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2289411 | romiDEPsin 10 MG in 2 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2289411 | romiDEPsin 10 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2289411 | romiDEPsin 10 MG in 2 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2289412 | romidepsin 5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2289412 | romidepsin 5 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2289413 | romiDEPsin 27.5 MG in 5.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2289413 | romiDEPsin 27.5 MG in 5.5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2289413 | romiDEPsin 27.5 MG in 5.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289413 | romiDEPsin 27.5 MG in 5.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289413 | romiDEPsin 27.5 MG in 5.5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2289413 | romiDEPsin 27.5 MG in 5.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289413 | romiDEPsin 27.5 MG in 5.5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2289414 | selumetinib 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2289415 | selumetinib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2289415 | selumetinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2289415 | selumetinib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2289416 | selumetinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2289417 | selumetinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2289418 | selumetinib 10 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2289418 | selumetinib 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289418 | selumetinib 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289418 | selumetinib 10 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2289418 | selumetinib 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2289419 | Koselugo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2289420 | selumetinib 10 MG [Koselugo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2289421 | selumetinib Oral Capsule [Koselugo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2289422 | Koselugo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2289423 | Koselugo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2289424 | Koselugo 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289424 | Koselugo 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289424 | Koselugo 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2289425 | selumetinib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2289426 | selumetinib 25 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2289426 | selumetinib 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289426 | selumetinib 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289426 | selumetinib 25 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2289426 | selumetinib 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2289427 | selumetinib 25 MG [Koselugo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2289428 | Koselugo 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2289428 | Koselugo 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2289428 | Koselugo 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2289429 | 1-butanol, 4-(ethenyloxy)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 22895 | dicloran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |